Boehringer Ingelheim, a Germany-based drugs company, has become a strategic partner of US-based digital health accelerator Rock Health. Rock Health also has as corporate partners: Switzerland-based drugs group Roche’s Genentech biotech subsidiary; Alexandria Real Estate Equities, which owns biotech buildings; and public relations firm Ogilvy. Rock has 11 start-ups for its latest accelerator programme, including CRIXlabs,…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
